GPT Healthcare Ltd reported Q3 FY26 (Dec quarter) revenue from operations at ₹1.2 billion, with profit after tax (PAT) reaching ₹93.7 million. This performance highlights steady growth in India's healthcare demand, driven by expanded facilities and efficient operations amid rising patient volumes.
GPT Healthcare Ltd, a key player in Eastern India's healthcare space with brands like Manipal Hospitals Dhulabhai, unveiled impressive Q3 FY26 results on Feb 2, 2026. Revenue from operations hit ₹1.2 billion, underscoring resilience in patient care services despite seasonal factors.
PAT stood at ₹93.7 million, signaling effective cost management and higher occupancy rates at its multi-specialty hospitals. The company, operating 1,365 beds across Jharkhand, Bihar, and West Bengal, benefits from growing medical tourism and infrastructure upgrades.
Investors anticipate deeper insights in the upcoming earnings call on Feb 3, potentially covering 9M FY26 outlook and expansion plans like the Jamshedpur hospital project. This positions GPT Healthcare for sustained growth in India's booming ₹20 lakh crore healthcare market.
Key Highlights
-
Revenue Surge: ₹1.2 billion from operations in Dec quarter FY26.
-
PAT Growth: ₹93.7 million, reflecting solid profitability.
-
Earnings Call Ahead: Scheduled for Feb 3, 2026, at 10 AM IST to discuss Q3 & 9M FY26 results.
-
Recent Trends: Builds on Q2 FY26 revenue of ₹118.9 crore (+12.5% YoY) and EBITDA ₹24.1 crore (20% margin).
-
Strategic Moves: Recent hospital pact in Jamshedpur and board changes support expansion.
-
Stock Snapshot: Shares at ~₹128.49 as of Feb 1, 2026 (-1.31% daily).
Sources: MarketScreener, Reuters via TradingView, ICICI Direct, Prysm